Left untreated, OSA is linked to daytime sleepiness and an increased ... A newer option is a surgically implanted device ...

Inspire Medical Systems focuses on providing innovative, FDA-approved solutions for obstructive sleep apnea (OSA). Its lead product, a minimally invasive neurostimulation system, is the only one ...

Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for ...

LivaNova (Nasdaq:LIVN) today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary ...

(AP) — Inspire Medical Systems Inc. (INSP ... The maker of devices for treating obstructive sleep apnea posted revenue of $203.2 million in the period, also surpassing Street forecasts.

(Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

About Inspire Medical Systems Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep ...